LINC00909

Across TCGA pan-cancer cohorts, LINC00909 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC00909’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC00909 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00909 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, KICH, and LUAD are the cancer types where LINC00909 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00909 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−0.932	<.001	10	view →
KICH	Female	All	−1.304	<.001	7	view →
LUAD	Female	II,III,IV	−0.593	<.001	6	view →
LIHC	Male	All	+0.514	<.001	6	view →
BRCA	Female	II,III,IV	−0.277	<.001	4	view →
CHOL	All	All	+1.437	<.001	3	view →
LUSC	Female	III,IV	−0.830	.026	3	view →
UCEC	All	All	−0.597	.003	2	view →
PRAD	All	All	−0.334	.002	2	view →
BLCA	Male	IV	−0.885	.005	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC00909–THCA

Open the THCA breakdown →